S&P 500   3,325.13 (+0.56%)
DOW   27,142.44 (+1.17%)
QQQ   270.97 (+0.22%)
AAPL   437.34 (-0.30%)
MSFT   212.71 (-0.27%)
FB   249.98 (+0.06%)
GOOGL   1,483.43 (+0.69%)
AMZN   3,189.53 (+1.62%)
NVDA   451.10 (+0.44%)
CGC   19.21 (-0.57%)
BABA   264.36 (+0.82%)
TSLA   1,488.00 (+0.07%)
MU   50.97 (-0.64%)
GE   6.15 (+0.16%)
AMD   85.21 (+0.20%)
T   29.82 (-0.63%)
F   6.97 (+1.60%)
ACB   10.71 (-0.19%)
GILD   69.48 (-1.98%)
NFLX   504.05 (-1.10%)
DIS   128.38 (+9.46%)
BAC   25.35 (+1.36%)
BA   173.59 (+5.16%)
S&P 500   3,325.13 (+0.56%)
DOW   27,142.44 (+1.17%)
QQQ   270.97 (+0.22%)
AAPL   437.34 (-0.30%)
MSFT   212.71 (-0.27%)
FB   249.98 (+0.06%)
GOOGL   1,483.43 (+0.69%)
AMZN   3,189.53 (+1.62%)
NVDA   451.10 (+0.44%)
CGC   19.21 (-0.57%)
BABA   264.36 (+0.82%)
TSLA   1,488.00 (+0.07%)
MU   50.97 (-0.64%)
GE   6.15 (+0.16%)
AMD   85.21 (+0.20%)
T   29.82 (-0.63%)
F   6.97 (+1.60%)
ACB   10.71 (-0.19%)
GILD   69.48 (-1.98%)
NFLX   504.05 (-1.10%)
DIS   128.38 (+9.46%)
BAC   25.35 (+1.36%)
BA   173.59 (+5.16%)
S&P 500   3,325.13 (+0.56%)
DOW   27,142.44 (+1.17%)
QQQ   270.97 (+0.22%)
AAPL   437.34 (-0.30%)
MSFT   212.71 (-0.27%)
FB   249.98 (+0.06%)
GOOGL   1,483.43 (+0.69%)
AMZN   3,189.53 (+1.62%)
NVDA   451.10 (+0.44%)
CGC   19.21 (-0.57%)
BABA   264.36 (+0.82%)
TSLA   1,488.00 (+0.07%)
MU   50.97 (-0.64%)
GE   6.15 (+0.16%)
AMD   85.21 (+0.20%)
T   29.82 (-0.63%)
F   6.97 (+1.60%)
ACB   10.71 (-0.19%)
GILD   69.48 (-1.98%)
NFLX   504.05 (-1.10%)
DIS   128.38 (+9.46%)
BAC   25.35 (+1.36%)
BA   173.59 (+5.16%)
S&P 500   3,325.13 (+0.56%)
DOW   27,142.44 (+1.17%)
QQQ   270.97 (+0.22%)
AAPL   437.34 (-0.30%)
MSFT   212.71 (-0.27%)
FB   249.98 (+0.06%)
GOOGL   1,483.43 (+0.69%)
AMZN   3,189.53 (+1.62%)
NVDA   451.10 (+0.44%)
CGC   19.21 (-0.57%)
BABA   264.36 (+0.82%)
TSLA   1,488.00 (+0.07%)
MU   50.97 (-0.64%)
GE   6.15 (+0.16%)
AMD   85.21 (+0.20%)
T   29.82 (-0.63%)
F   6.97 (+1.60%)
ACB   10.71 (-0.19%)
GILD   69.48 (-1.98%)
NFLX   504.05 (-1.10%)
DIS   128.38 (+9.46%)
BAC   25.35 (+1.36%)
BA   173.59 (+5.16%)
Log in

NASDAQ:ORICORIC Pharmaceuticals News Headlines

$22.68
+0.13 (+0.58 %)
(As of 08/5/2020 12:54 PM ET)
Add
Compare
Today's Range
$22.31
Now: $22.68▼
$23.87
50-Day Range
$20.07
MA: $27.93▼
$38.12
52-Week Range
$19.85
Now: $22.68▼
$40.67
Volume1,776 shs
Average Volume192,657 shs
Market Capitalization$652.96 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Headlines

ORIC Pharmaceuticals (NASDAQ ORIC) News Headlines

Source:
DateHeadline
PMV Pharma Closes $70 Million in Series D FinancingPMV Pharma Closes $70 Million in Series D Financing
benzinga.com - August 4 at 12:37 AM
ORIC Pharmaceuticals to Host Second Quarter 2020 Financial Results Conference CallORIC Pharmaceuticals to Host Second Quarter 2020 Financial Results Conference Call
finance.yahoo.com - August 4 at 12:37 AM
Passage Bio (NASDAQ:ORIC) Stock Price Up 9.9%Passage Bio (NASDAQ:ORIC) Stock Price Up 9.9%
americanbankingnews.com - August 3 at 7:47 PM
HC Wainwright Begins Coverage on Passage Bio (NASDAQ:ORIC)HC Wainwright Begins Coverage on Passage Bio (NASDAQ:ORIC)
www.americanbankingnews.com - August 3 at 8:25 AM
Passage Bio (NASDAQ:ORIC) Receives Average Recommendation of "Buy" from AnalystsPassage Bio (NASDAQ:ORIC) Receives Average Recommendation of "Buy" from Analysts
www.americanbankingnews.com - July 31 at 6:10 AM
Passage Bio (NASDAQ:ORIC) Hits New 1-Year Low at $21.25Passage Bio (NASDAQ:ORIC) Hits New 1-Year Low at $21.25
www.americanbankingnews.com - July 30 at 6:08 AM
Passage Bio (NASDAQ:ORIC) Trading 9.2% Higher Passage Bio (NASDAQ:ORIC) Trading 9.2% Higher
www.americanbankingnews.com - July 28 at 7:38 PM
Passage Bio (NASDAQ:ORIC) Reaches New 1-Year Low at $22.29Passage Bio (NASDAQ:ORIC) Reaches New 1-Year Low at $22.29
www.americanbankingnews.com - July 24 at 2:26 PM
ORIC Pharmaceuticals Presents Preclinical Data on Glucocorticoid Receptor Antagonist and CD73 Inhibitor Programs at the 2020 American Association for Cancer Research Virtual Annual Meeting IIORIC Pharmaceuticals Presents Preclinical Data on Glucocorticoid Receptor Antagonist and CD73 Inhibitor Programs at the 2020 American Association for Cancer Research Virtual Annual Meeting II
finance.yahoo.com - June 22 at 1:04 PM
ORIC Pharmaceuticals Announces Five Presentations at the 2020 American Association for Cancer Research Virtual Annual Meeting IIORIC Pharmaceuticals Announces Five Presentations at the 2020 American Association for Cancer Research Virtual Annual Meeting II
finance.yahoo.com - May 27 at 7:20 AM
ORIC Pharmaceuticals to Present at the Jefferies 2020 Global Healthcare ConferenceORIC Pharmaceuticals to Present at the Jefferies 2020 Global Healthcare Conference
finance.yahoo.com - May 26 at 10:18 AM
ORIC Pharmaceuticals Reports First Quarter 2020 Financial and Operational ResultsORIC Pharmaceuticals Reports First Quarter 2020 Financial and Operational Results
finance.yahoo.com - May 20 at 8:27 PM
ORIC Pharmaceuticals Presents Preclinical Data on CD73 Inhibitor at the American Association for Cancer Research (AACR) Virtual Annual MeetingORIC Pharmaceuticals Presents Preclinical Data on CD73 Inhibitor at the American Association for Cancer Research (AACR) Virtual Annual Meeting
finance.yahoo.com - April 30 at 5:58 PM
ORIC Pharmaceuticals Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional SharesORIC Pharmaceuticals Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
finance.yahoo.com - April 30 at 5:58 PM
This page was last updated on 8/5/2020 by MarketBeat.com Staff
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.